Key points from article :
Phenomix Sciences, a precision medicine biotech company founded by Mayo Clinic physicians, has secured $7.8 million in funding to advance their obesity treatment technology.
Their MyPhenome test identifies different obesity types, like "Hungry Gut" or "Emotional Hunger," to personalize treatment plans for patients.
This funding, including investments from DexCom and Labcorp and a grant from the National Institutes of Health, will help expand the test's availability and fund further research to validate its effectiveness.
Phenomix aims to tackle the obesity epidemic with a more tailored approach, considering lifestyle changes, diet, medication, and procedures.
The company's work has garnered attention from major industry players, highlighting the importance of their research in the field of obesity treatment.
